Do you want to read an article? Please log in or register.
Reduction in TIMP-2 serum levels predicts remission of inflammatory bowel diseases
Inflammatory Bowel Disease
Related content
Inflammatory Bowel Disease
Early vedolizumab trough levels predict combined endoscopic and clinical remission in inflammatory bowel disease
United European Gastroenterol J.
Hanžel J, Sever N, Ferkolj I, Štabuc B, Smrekar N, Kurent T, Koželj M, Novak G, Compernolle G, Tops S, Gils A, Drobne D
doi: 10.1177/2050640619840211.
Inflammatory Bowel Disease
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease
United European Gastroenterol J.
Guidi L, Pugliese D, Tonucci TP, Bertani L, Costa F, Privitera G, Tolusso B, Di Mario C, Albano E, Tapete G, Gremese E, Papa A, Gasbarrini A, Rapaccini GL, Armuzzi A
doi: 10.1177/2050640619873784.
Inflammatory Bowel Disease
High Patient Activation Is Associated With Remission in Patients With Inflammatory Bowel Disease
Inflamm Bowel Dis.
Barnes EL, Long MD, Kappelman MD, Martin CF, Sandler RS
doi: 10.1093/ibd/izy378.
Inflammatory Bowel Disease
Association Between Low Trough Levels of Vedolizumab During Induction Therapy for Inflammatory Bowel Diseases and Need for Additional Doses Within 6 Months
Clin Gastroenterol Hepatol.
Williet N, Boschetti G, Fovet M, Di Bernado T, Claudez P, Del Tedesco E, Jarlot C, Rinaldi L, Berger A, Phelip JM, Flourie B, Nancey S, Paul S, Roblin X
doi: 10.1016/j.cgh.2016.11.023.
Inflammatory Bowel Disease
Effect of distance to specialist care for the diagnosis and disease outcome of inflammatory bowel disease in the Swiss inflammatory bowel disease cohort study
Therap Adv Gastroenterol.
Grob L, Bluemel S, Biedermann L, Fournier N, Rossel JB, Vavricka SR, Zeitz J, Rogler G, Stallmach A, Scharl M
doi: 10.1177/1756284819895217.
Inflammatory Bowel Disease
Illness Perception in Inflammatory Bowel Disease Patients is Different Between Patients With Active Disease or in Remission: A Prospective Cohort Study
doi: 10.1093/ecco-jcc/jjy183.
Inflammatory Bowel Disease
Infliximab trough levels are decreasing over time in patients with inflammatory bowel disease on maintenance treatment with infliximab
doi: 10.1097/MEG.
RECOMMENDED
Inflammatory Bowel Disease
Serum Biomarkers Identify Patients Who Will Develop Inflammatory Bowel Diseases Up to 5 y Before Diagnosis
★ 1
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
Gastroenterology.
Torres J, Petralia F, Sato T, Wang P, Telesco SE, Choung RS, Strauss R, Li XJ, Laird RM, Gutierrez RL, Porter CK, Plevy S, Princen F, Murray JA, Riddle MS, Colombel JF
doi: 10.1053/j.gastro.2020.03.007.
Inflammatory Bowel Disease
Circulating Leptin Levels as a Potential Biomarker in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis
Inflamm Bowel Dis.
Carvalho LGF, Lima WG, Coelho LGV, Cardoso VN, Fernandes SOA
doi: 10.1093/ibd/izaa037.